Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Every urologist and oncologist should know about treating sexual and gender minority prostate cancer patients: translating research findings into clinical practice.
Rosser BRS, Rider GN, Kapoor A, Talley KMC, Haggart R, Kohli N, Konety BR, Mitteldorf D, Polter EJ, Ross MW, West W, Wheldon C, Wright M. Rosser BRS, et al. Among authors: haggart r. Transl Androl Urol. 2021 Jul;10(7):3208-3225. doi: 10.21037/tau-20-1052. Transl Androl Urol. 2021. PMID: 34430423 Free PMC article. Review.
Comorbidity Prevalence and Impact on Quality of Life in Gay and Bisexual Men Following Prostate Cancer Treatment.
Haggart R, Polter E, Ross M, Kohli N, Konety BR, Mitteldorf D, West W, Rosser BRS. Haggart R, et al. Sex Med. 2021 Dec;9(6):100439. doi: 10.1016/j.esxm.2021.100439. Epub 2021 Oct 8. Sex Med. 2021. PMID: 34634579 Free PMC article.
If confirmed in larger, longitudinal, clinically confirmed studies, these findings indicate a need to intervene on and consider comorbidities in GBM diagnosed with prostate cancer. Haggart R, Polter E, Ross M, et al. Comorbidity Prevalence and Impact on Quality of L …
If confirmed in larger, longitudinal, clinically confirmed studies, these findings indicate a need to intervene on and consider comorbiditie …
Prostate cancer disclosure and sexual orientation: Understanding outness to healthcare providers as a situational or consistent phenomenon.
Wells-Prado DR, Ross MW, Rosser BRS, Polter EJ, Capistrant BD, Haggart R, Kohli N, Konety BR, Mitteldorf D, Talley KMC, West W, Wheldon CW. Wells-Prado DR, et al. Among authors: haggart r. Patient Educ Couns. 2022 Jul;105(7):2033-2037. doi: 10.1016/j.pec.2021.11.017. Epub 2021 Nov 24. Patient Educ Couns. 2022. PMID: 34865891 Free PMC article.
Creation and Psychometric Validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in Sexual Minority Patients-The Restore-2 Study.
Polter EJ, Kohli N, Rosser BRS, Talley KMC, Wheldon CW, Hoefer CJ, Wright M, Haggart R, Mitteldorf D, Kilian G, Konety BR, Ross MW, West W. Polter EJ, et al. Among authors: haggart r. J Sex Med. 2022 Mar;19(3):529-540. doi: 10.1016/j.jsxm.2021.12.012. Epub 2022 Feb 4. J Sex Med. 2022. PMID: 35131199 Free PMC article.
Recruiting an underserved, difficult to reach population into a cancer trial: Strategies from the Restore-2 Rehabilitation Trial for gay and bisexual prostate cancer patients.
Simon Rosser BR, Wright M, Hoefer CJ, Polter EJ, Kohli N, Wheldon CW, Haggart R, Talley KM, Mitteldorf D, Kilian G, Konety BR, Ross MW, West W. Simon Rosser BR, et al. Among authors: haggart r. Clin Trials. 2022 Jun;19(3):239-250. doi: 10.1177/17407745221077678. Epub 2022 Mar 1. Clin Trials. 2022. PMID: 35232299 Free PMC article. Clinical Trial.
Prevalence and Risk Factors for Sexually Transmitted Infections in Gay and Bisexual Prostate Cancer Survivors: Results From the Restore-2 Study.
Wheldon CW, Polter E, Rosser BRS, Bates AJ, Haggart R, Wright M, Mitteldorf D, Ross MW, Konety BR, Kohli N, Talley KMC, West W, Tatum AK. Wheldon CW, et al. Among authors: haggart r. Front Oncol. 2022 May 5;12:832508. doi: 10.3389/fonc.2022.832508. eCollection 2022. Front Oncol. 2022. PMID: 35600390 Free PMC article.
26 results